Biotech Specialty Pharma

AcuityBio Corporation

200 Upland Rd
Newton, Massachusetts 24602423 U.S
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Commercializes polymer drugdelivery technologies to treat soft tissue cancers.

Management Mark Grinstaff, Ph.D.; Alain Hanover, M.S.; Jesse Wolinsky, Ph.D.; and John 'Jay' Schwartz, Ph.D

Click here for Financial Data
Keywords: KIP2018, Novel, polymer, drug delivery, technologies, soft tissue, cancer, Oncology


Updated: Apr. 20, 2018


AcuityBio was founded by Mark Grinstaff, Ph.D., Alain Hanover, M.S., Jesse Wolinsky, Ph.D., and John 'Jay' Schwartz, Ph.D. in late 2008 to commercialize novel polymer drug delivery technologies to tre......view more

Products / Services

ABC Polymer......view more

Technology / Differentiation

AcuityBio has developed a unique, and simple to use, drug-eluting implant that reduces the incidence of locoregional lung cancer recurrence by locally delivering therapeutic levels of drug to the site...view more